<--- Back to Details
First PageDocument Content
Pharmacology / HIV/AIDS / Stavudine / Antiretroviral drug / Reverse-transcriptase inhibitor / Purines / Adverse drug reaction / Lactic acidosis / Mitochondrial toxicity / Medicine / Bristol-Myers Squibb / Health
Date: 2014-02-05 12:25:58
Pharmacology
HIV/AIDS
Stavudine
Antiretroviral drug
Reverse-transcriptase inhibitor
Purines
Adverse drug reaction
Lactic acidosis
Mitochondrial toxicity
Medicine
Bristol-Myers Squibb
Health

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 414

Add to Reading List

Source URL: www.aidsinfonet.org

Download Document from Source Website

File Size: 92,42 KB

Share Document on Facebook

Similar Documents

Pharmaceutical industry / Package insert / Packaging / Insert / Business / Economy

Reference material Standard Workflow for the Revision of Drug Product Package Inserts (Adverse Drug Reaction Reports, etc.)

DocID: 1rsP1 - View Document

Medical research / Pharmaceuticals policy / Health care / Health / Clinical research / Clinical pharmacology / Clinical trials / Drug safety / Pharmacovigilance / Adverse drug reaction / Nonsteroidal anti-inflammatory drug / Yellow Card Scheme

Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad

DocID: 1rcEG - View Document

Pharmaceuticals policy / Clinical research / Clinical pharmacology / Drug safety / World Health Organization / Pharmacovigilance / Uppsala Monitoring Centre / VigiBase / Adverse effect / Adverse drug reaction / Serious adverse event / Adverse event

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,

DocID: 1p9e5 - View Document

Medical terminology / Patient safety / Healthcare quality / Clinical pharmacology / Medical ethics / Medical error / Electronic health record / Adverse effect / Adverse event / Never events / Antimicrobial stewardship / Adverse drug reaction

REVIEW ARTICLE A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care John T. James, PhD

DocID: 1p3Uj - View Document

Pharmaceuticals policy / Clinical research / Drug safety / Clinical pharmacology / Healthcare quality / Veterinary Medicines Directorate / Pharmacovigilance / European Medicines Agency / Suspected Adverse Reaction Surveillance Scheme / Adverse effect / Adverse event / National Office of Animal Health

Pharmacovigilance: Monitoring the Safety & Efficacy of Animal Medicines Summary This document

DocID: 1oBM7 - View Document